PharmaPlus Consultancy is an experienced advisor on pre-commercial stage biopharmaceutical licensing deals. We bring value to all stages of licensing transactions, from sourcing through closing.
We identify, analyze, commercialize and valuate potential biopharmaceutical licensing opportunities.
Our approach balances new and innovative as well as traditional solutions tailored specifically to your needs. We offer our services on a worldwide basis and use a unique combination of our proprietary in-house partnering search & licensing deal databases and an international network of partners.
Our experience covers multiple disease areas, including autoimmune disorders, blood & blood forming organs, bone disorders, cardiovascular disorders, CNS disorders, dermatology, eye disorders, gastrointestinal disorders, genetic disorders, infectious diseases, inflammatory disorders, musculoskeletal disorders, oncology, respiratory disorders, transplantation, vaccines, antibody technologies, imaging, specialty generics and diagnostics.
Every client engagement is unique to the objectives, requirements and limitations of our client.
Given the nature of our work, our client activities are strictly confidential.
Karin Bakker is founder and principal of PharmaPlus Consultancy and has spent her entire 20+ year career in the life science sector. She provides a unique perspective that bridges industry and academia, business and science.
Since 1996 Karin has consulted for a large variety of organizations with an interest in the life science sector. She approaches engagements with professionalism and persistence to help achieve performance on behalf of clients and has concluded multi-millions of dollars of transactions for clients.
Previously Karin co-founded consultancy company Bakker & Pronk, delivering project management, disease management, reimbursement services and market studies for the Dutch market to clients like ALK-Abelló, Alliance Boots, Merck Organon (Merck & Co) Merck Serono and Sanofi.
Karin worked at NPBI (Fresenius), where she was responsible for international business development and project management and facilitated the company’s first licensing deal for the US market. She has a degree in pharmacy.